Company / PP&E (Net)
Caris Life Sciences, Inc. PP&E (Net) History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$63.2M
FY2025
5-year range
$63.2M / $63.2M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#99 of 138
Health Care
What the data says
At $63M, Caris Life Sciences, Inc.'s pp&e (net) ranks #99 of 138 in the Health Care sector.
Based on SEC 10-K filings.
$63M in FY2025.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#99 of 138 in Health CareTop 72% of 138This company $63.2M Sector average $1.4B
▼
-95.5% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $63.2M | - |
| FY2024 | - | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026